<DOC>
	<DOCNO>NCT00043589</DOCNO>
	<brief_summary>This study evaluate effectiveness donepezil ( AriceptÂ® ) cognitive train improve memory performance elderly adult .</brief_summary>
	<brief_title>Memory Mental Health Aging</brief_title>
	<detailed_description>The drug donepezil plus cognitive training may work well cognitive training alone improve memory nondemented old adult . In study , participant assign randomly receive either donepezil plus cognitive training placebo plus cognitive training . Memory quality life test use evaluate effect study treatment .</detailed_description>
	<mesh_term>Memory Disorders</mesh_term>
	<mesh_term>Donepezil</mesh_term>
	<criteria>MiniMental Exam score 24 30 Hamilton Depression Score 12 less 17item scale Visual auditory acuity adequate neuropsychological test General good health ( additional disease expect interfere study ) Normal B12 , Rapid Plasma Reagin ( RPR ) , Thyroid Function Tests Normal general clinical chemistry , complete blood count , electrocardiogram ( ECG ) Female participant must 2 year postmenopausal surgically sterile Significant neurologic disease Possible probable Alzheimer 's Disease ( AD ) Parkinson 's disease Multiinfarct dementia Huntington 's disease Normal pressure hydrocephalus Brain tumor Progressive supranuclear palsy Seizure disorder Subdural hematoma Multiple sclerosis History significant head trauma follow persistent neurologic default know structural brain abnormality Major depression major psychiatric disorder describe DSM IV within past 2 year Psychotic feature , agitation , behavioral problem within last 3 month History alcohol substance abuse dependence within past 2 year Significant systemic illness unstable medical condition include : ) history systemic cancer within last 5 year ( nonmetastatic skin cancer acceptable ) ; b ) history myocardial infarction within past year unstable severe cardiovascular disease , include angina CHF symptom rest ; c ) clinically significant obstructive pulmonary disease asthma ; ) clinically significant unstable gastrointestinal disorder ulcer disease history active occult gastrointestinal bleeding within 2 year ; e ) clinically significant laboratory test abnormality battery screen test ( hematology , prothrombin time , chemistry , urinalysis , ECG ) ; f ) insulinrequiring diabetes uncontrolled diabetes mellitus ; g ) uncontrolled hypertension ( systolic BP great 170 diastolic great 100 ) ; h ) history clinically significant liver disease , coagulopathy , vitamin K deficiency within past 2 year Use centrally active betablockers , narcotic , methyldopa , clonidine within 4 week prior screen Use antiParkinsonian medication ( e.g . Sinemet , amantadine , bromocriptine , pergolide , selegiline ) within 2 month prior screen Use neuroleptic narcotic analgesic within 4 week prior screen Use longacting benzodiazepine barbiturate within 4 week prior screen Use shortacting anxiolytic sedative hypnotic frequently 2 time per week within 4 week prior screen ( note : sedative agent use within 72 hour screen ) Initiation change dose antidepressant lacking significant cholinergic side effect within 4 week prior screen ( use stable dos antidepressant least 4 week prior screen acceptable ) Use systemic corticosteroid within 3 month prior screen Medications significant cholinergic anticholinergic side effect ( e.g . pyridostigmine , tricyclic antidepressant , meclizine , oxybutynin ) within 4 week prior screen Use anticonvulsant ( e.g . Phenytoin , Phenobarbital , Carbamazepine ) within 2 month prior screen Use warfarin ( Coumadin ) within 4 week prior screen Prior use FDA approve medication treatment AD ( e.g . tacrine , donepezil , newly approve medication )</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Memory</keyword>
</DOC>